Sejong Medical KRX:258830KOSDAQ
세종메디칼 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked22since Sep 11
In Q2 2026, Sejong Medical reported revenue of ₩5.0bn, up 7.1% year on year, and operating profit of ₩1.4bn. Sejong Medical (세종메디칼) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Sejong Medical quarterly results separate, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩5.0bn | +7.1% | ₩1.4bn margin 28.7% | ₩1.9bn |
| Q1 2026 | ₩4.9bn | +9.5% | ₩927m margin 19.0% | ₩978m |
| Q4 2025 derived | ₩4.5bn | +0.9% | ₩673m margin 14.8% | −₩3.2bn |
| Q3 2025 | ₩4.9bn | -0.6% | ₩1.1bn margin 23.3% | ₩1.2bn |
| Q2 2025 | ₩4.6bn | +4.2% | ₩740m margin 16.0% | −₩140m |
| Q1 2025 | ₩4.4bn | -12.2% | −₩293m margin −6.6% | ₩2.1bn |
| Q4 2024 derived | ₩4.5bn | -7.3% | ₩250m margin 5.6% | −₩358m |
| Q3 2024 | ₩5.0bn | +5.9% | ₩249m margin 5.0% | −₩365m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Sejong Medical top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Sejong Medical news Korean headlines
-
서영교 "제넨셀, 세종메디칼과 무관"…김승원 전화 나흘 전 투자협상 있었다
1 more on this story · 1 outlets
- 서영교 "제넨셀, 세종메디칼과 무관"…김승원 전화 나흘 전 투자협상 있었다이데일리 · Sep 15 18:22
-
[포토] 제넨셀·세종메디칼 피해자 기자회견
2 more on this story · 2 outlets
- 박정훈 의원이 연 제넨셀·세종메디칼 주가조작 피해자 기자회견데일리한국 · Sep 11 17:01
- 박정훈 의원이 연 제넨셀·세종메디칼 주가조작 피해자 기자회견한국일보 · Sep 11 17:01